182 related articles for article (PubMed ID: 36277293)
21. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
[TBL] [Abstract][Full Text] [Related]
22. Preoperative prediction of pancreatic neuroendocrine tumor grade based on
Ma J; Wang X; Tang M; Zhang C
Endocrine; 2024 Feb; 83(2):502-510. PubMed ID: 37715934
[TBL] [Abstract][Full Text] [Related]
23. Imaging of neuroendocrine tumors of the pancreas.
Dromain C; Déandréis D; Scoazec JY; Goere D; Ducreux M; Baudin E; Tselikas L
Diagn Interv Imaging; 2016 Dec; 97(12):1241-1257. PubMed ID: 27876341
[TBL] [Abstract][Full Text] [Related]
24. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract][Full Text] [Related]
25. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
[TBL] [Abstract][Full Text] [Related]
26. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
Khashab MA; Yong E; Lennon AM; Shin EJ; Amateau S; Hruban RH; Olino K; Giday S; Fishman EK; Wolfgang CL; Edil BH; Makary M; Canto MI
Gastrointest Endosc; 2011 Apr; 73(4):691-6. PubMed ID: 21067742
[TBL] [Abstract][Full Text] [Related]
27. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
Kim YI; Kim SK; Paeng JC; Lee HY
Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
[TBL] [Abstract][Full Text] [Related]
29. B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors.
Braden B; Jenssen C; D'Onofrio M; Hocke M; Will U; Möller K; Ignee A; Dong Y; Cui XW; Sãftoiu A; Dietrich CF
Endosc Ultrasound; 2017; 6(1):49-54. PubMed ID: 28218201
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.
Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X
Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
32. Radiomics Analysis Based on Diffusion Kurtosis Imaging and T2 Weighted Imaging for Differentiation of Pancreatic Neuroendocrine Tumors From Solid Pseudopapillary Tumors.
Shi YJ; Zhu HT; Liu YL; Wei YY; Qin XB; Zhang XY; Li XT; Sun YS
Front Oncol; 2020; 10():1624. PubMed ID: 32974201
[TBL] [Abstract][Full Text] [Related]
33. Added value of [
Yoo J; Kim SH; Jeon SK; Bae JS; Han JK
Eur Radiol; 2021 Oct; 31(10):7734-7745. PubMed ID: 33787974
[TBL] [Abstract][Full Text] [Related]
34. Multidetector CT imaging features of solid pseudopapillary tumours of the pancreas in male patients: distinctive imaging features with female patients.
Park MJ; Lee JH; Kim JK; Kim YC; Park MS; Yu JS; Kim YB; Lee D
Br J Radiol; 2014 Mar; 87(1035):20130513. PubMed ID: 24472726
[TBL] [Abstract][Full Text] [Related]
35. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
Jilesen AP; Hoefnagel SJ; Busch OR; Bennink RJ; Gouma DJ; Nieveen van Dijkum EJ
Clin Radiol; 2016 Jun; 71(6):537-42. PubMed ID: 27016111
[TBL] [Abstract][Full Text] [Related]
36. Solid pseudopapillary tumor of the pancreas: clinical features and imaging findings.
Li DL; Li HS; Xu YK; Wang QS; Chen RY; Zhou F
Clin Imaging; 2018; 48():113-121. PubMed ID: 29073488
[TBL] [Abstract][Full Text] [Related]
37. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
39. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
[TBL] [Abstract][Full Text] [Related]
40. Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors: Clinicopathological Analysis of 223 Cases and Whole Exome Sequencing of a Multifocal Case.
Hu HF; Hu YH; Xu XW; Ye Z; Lou X; Zhang WH; Chen XM; Zhang Y; Yu XJ; Gao HL; Xu JY; Ji SR
Pancreas; 2022 Nov-Dec 01; 51(10):1404-1410. PubMed ID: 37099786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
